Lesleigh Thomas, PA
Physician Assistant · Concord, NCNPI 1962071415
Payments from drug & device makers
Across 166 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$451
- Medtronic$427
- Astellas Pharma US Inc$373
- C. R. Bard, Inc. & Subsidiaries$363
- Regeneron Healthcare Solutions, Inc.$207
- Boston Scientific$197
- plus $2K from 31 others
What the payments were for
- Consulting fees$160%
- Travel & lodging$2266%
- Food & beverage$3,33190%
- Education$1314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $451 |
| Medtronic | 5 | $427 |
| Astellas Pharma US Inc | 12 | $373 |
| C. R. Bard, Inc. & Subsidiaries | 39 | $363 |
| Regeneron Healthcare Solutions, Inc. | 8 | $207 |
| Boston Scientific | 9 | $197 |
| CSL Behring | 6 | $165 |
| Teleflex LLC | 3 | $140 |
| Endo Pharmaceuticals Inc. | 9 | $131 |
| AbbVie(2 entities) | 6 | $111 |
| Sumitomo Pharma America, Inc. | 5 | $108 |
| Urovant Sciences Inc | 5 | $92 |
| Procept Biorobotics Corporation | 2 | $82 |
| Rochester Medical Corporation | 3 | $82 |
| Convatec Inc. | 2 | $82 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $71 |
| Mission Pharmacal Company | 4 | $57 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Davol Inc. | 1 | $48 |
| Coloplast | 3 | $48 |
| Optinose US, Inc. | 2 | $42 |
| Progenics Pharmaceuticals, Inc. | 2 | $37 |
| Urogen Pharma, Inc. | 1 | $36 |
| Hollister Incorporated | 2 | $36 |
| Incyte Corporation | 2 | $31 |
| Biocryst US Sales Co., LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Pfizer | 1 | $23 |
| 180 Medical, Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| ADMA Biomanufacturing LLC | 1 | $16 |
| Sanofi | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
| Accord Healthcare, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,704 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 95 | $69,534 |
| MyrbetriqMirabegron | 83 | $61,605 |
| Solifenacin Succinate | 87 | $5,507 |
| Tamsulosin Hcl | 311 | $4,861 |
| Estradiol | 30 | $2,090 |
| Finasteride | 178 | $1,707 |
| Methenamine Hippurate | 33 | $1,610 |
| Oxybutynin Chloride ErOxybutynin Chloride | 67 | $1,115 |
| Oxybutynin Chloride | 46 | $810 |
| Bethanechol Chloride | 15 | $721 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $585 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 25 | $567 |
| Testosterone Cypionate | 11 | $415 |
| Cephalexin | 22 | $407 |
| Trospium Chloride | 14 | $332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $108 | $69,53495 claims |
| Astellas Pharma US IncMyrbetriq | $373 | $61,60583 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Concord
- Harold SmithConcord$25K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.